ClinicalTrials.Veeva

Menu

Clinical Characterization of an Investigational Soft Silicone Hydrogel Contact Lens

Alcon logo

Alcon

Status

Completed

Conditions

Refractive Errors

Treatments

Device: Multipurpose disinfection solution
Device: Lehfilcon A contact lenses

Study type

Interventional

Funder types

Industry

Identifiers

NCT04631796
CLY935-E006

Details and patient eligibility

About

The primary objective of this study is to evaluate the overall clinical performance of an investigational silicone hydrogel contact lens over 2 weeks of daily wear.

Full description

Participants will attend a Screening visit, a Dispense visit (0 to 4 days later), and a follow-up visit approximately 2 weeks after the Dispense visit.

Enrollment

36 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Understand and sign an Informed Consent that has been approved by an Institutional Review Board.
  • Successful wear of spherical weekly/monthly soft contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months.
  • Willing to stop wearing habitual contact lenses for the duration of study participation.
  • Other protocol-defined inclusion criteria may apply.

Exclusion criteria

  • Any condition that contraindicates contact lens wear, as determined by the Investigator.
  • Any use of systemic or ocular medications that contraindicates contact lens wear, as determined by the Investigator.
  • History of refractive surgery or plan to have refractive surgery during the study.
  • Current or history of dry eye in either eye that, in the opinion of the Investigator, would preclude contact lens wear.
  • Habitual contact lenses worn in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment.
  • Any use of topical ocular medications or artificial tear or rewetting drops that would require instillation during contact lens wear.
  • Monovision or multifocal contact lens wear.
  • Other protocol-defined exclusion criteria may apply.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

36 participants in 1 patient group

LID020098
Experimental group
Description:
Lehfilcon A contact lenses worn in both eyes for 2 weeks. Lenses will be removed nightly for cleaning and disinfection.
Treatment:
Device: Lehfilcon A contact lenses
Device: Multipurpose disinfection solution

Trial documents
2

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems